- No title available in English
-
Kim JS
- KMID: 2376168
- Korean J Endocr Surg.
- 2002 Dec;2(2):80-82.
- doi: 10.16956/kjes.2002.2.2.80
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- No title available in English
-
Chung WY, Park CS
- KMID: 2376178
- Korean J Endocr Surg.
- 2002 Dec;2(2):130-132.
- doi: 10.16956/kjes.2002.2.2.130
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- No title available in English
-
Park YL, Bae WG
- KMID: 2376167
- Korean J Endocr Surg.
- 2002 Dec;2(2):77-79.
- doi: 10.16956/kjes.2002.2.2.77
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- No title available in English
-
Kim JS, Chung WY, Park CS
- KMID: 2376177
- Korean J Endocr Surg.
- 2002 Dec;2(2):128-129.
- doi: 10.16956/kjes.2002.2.2.128
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- No title available in English
-
Park CS, Choi GH, Chung WY, Kim EK
- KMID: 2376176
- Korean J Endocr Surg.
- 2002 Dec;2(2):124-127.
- doi: 10.16956/kjes.2002.2.2.124
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Increased Expression of Cyclooxygenase-2 Protein in Human Thyroid Tumor
-
Lee KJ, Park HB, Kim JH, Jeong YS, Joo HJ, Soh EY
- KMID: 2376170
- Korean J Endocr Surg.
- 2002 Dec;2(2):90-96.
- doi: 10.16956/kjes.2002.2.2.90
PURPOSE: Thyroid tumor is one of the most common endocrine tumors, and yet little is known about its molecular process of development and progression. Cyclooxygenase (COX)-2, the inducible form of... -
- CITED
-
- Close
- SHARE
-
- Close
- Ectopic ACTH Syndrome Due to Pheochromocytoma: A case report
-
Hong SJ, Kim WB
- KMID: 2376174
- Korean J Endocr Surg.
- 2002 Dec;2(2):116-119.
- doi: 10.16956/kjes.2002.2.2.116
A 28-year old female was diagnosed preoperatively to have a pheochromocytoma producing ACTH at other hospital. However the operation was delayed due to poor general condition and abnormal liver function.... -
- CITED
-
- Close
- SHARE
-
- Close
- Redifferentiation Therapy in Thyroid Cancer
-
Park JW
- KMID: 2376169
- Korean J Endocr Surg.
- 2002 Dec;2(2):83-89.
- doi: 10.16956/kjes.2002.2.2.83
Differentiated thyroid cancer of follicular cell origin (DTC) is a fascinating tumor because of its varying aggressiveness. Luckily most patients with these cancers, despite regional metastasis, can be cured by... -
- CITED
-
- Close
- SHARE
-
- Close
- Chylous Fistula after Surgery for Papillary Thyroid Carcinoma
-
Park JD, Hong SJ
- KMID: 2376173
- Korean J Endocr Surg.
- 2002 Dec;2(2):109-115.
- doi: 10.16956/kjes.2002.2.2.109
PURPOSE: Most of postoperative chylous fistula in the neck occur after lateral neck lymph node dissection. However we experienced chylous fistulas in the central neck as well as lateral neck... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Findings and Risk for Malignancy in Thyroid Nodules with Cytological Diagnosis of the so-called ‘Follicular Neoplasm’
-
Kim ES, Nam-Goong , Gong G, Hong SJ, Kim WB, Shong YK
- KMID: 2376172
- Korean J Endocr Surg.
- 2002 Dec;2(2):105-108.
- doi: 10.16956/kjes.2002.2.2.105
PURPOSE: To assess the prevalence and the risk of malignancy in thyroid nodules which were cytologically diagnosed as follicular neoplasm by fine-needle aspiration (FNA) cytology. METHODS: All the patients who had... -
- CITED
-
- Close
- SHARE
-
- Close
- Malignant Glucagonoma of the Pancreas: A case report
-
Yun JY, Jeong JG, Jeong UG, Park MO
- KMID: 2376175
- Korean J Endocr Surg.
- 2002 Dec;2(2):120-123.
- doi: 10.16956/kjes.2002.2.2.120
Glucagonomas are rare pancreatic tumors of islet ahpha-2 cells. Less than 430 cases have been reported worldwide and 210 cases are malignant tumors. In generally, the tumors typically present with... -
- CITED
-
- Close
- SHARE
-
- Close
- Verification of Measurement Methods and Therapeutic Efficacy of Maximum Permissible Dose of I-131 in High Risk Patients with Differentiated Papillary Thyroid Cancer
-
Kim JC, Yoon JH, Jaegal YJ, Bum HS
- KMID: 2376171
- Korean J Endocr Surg.
- 2002 Dec;2(2):97-104.
- doi: 10.16956/kjes.2002.2.2.97
PURPOSE: Radioiodine (I-131) therapy is an effective modality to reduce both recurrence and mortality rates in differentiated thyroid cancer. Whether higher doses shows higher therapeutic responses was still debatable. The... -
- CITED
-
- Close
- SHARE
-
- Close
